High-Quality Deslorelin CAS 57773-65-6: China Suppliers & Factory for Synthetic GnRH Analog Products Manufacturer, Manufacturers
Deslorelin is a synthetic gonadotropin-releasing hormone (GnRH) analog that exhibits a potency 30 to 150 times greater than that of natural GnRH. As a powerful GnRH agonist, it initially prompts the pituitary gland to release gonadotropins, creating a flare-up effect. Over time, Deslorelin's sustained agonistic action leads to desensitization of the pituitary gland and downregulation of GnRH receptors. This process effectively inhibits the release of gonadotropins, such as LH and FSH, ultimately suppressing the production of sex steroid hormones. As a leading supplier and factory in China, we are committed to providing high-quality Deslorelin to meet the needs of our clients and support advancements in hormone-related therapies
Deslorelin is a synthetic gonadotropin-releasing hormone (GnRH) analog with a potency approximately 30–150 times that of natural GnRH. As a GnRH agonist, it initially and briefly stimulates the pituitary gland to release gonadotropins (the "flare-up" effect). Subsequently, through sustained agonistic action, it leads to pituitary desensitization and downregulation of GnRH receptors, thereby inhibiting the secretion of gonadotropins (LH, FSH) and ultimately suppressing the production of sex steroid hormones.
Therapeutic Areas
Veterinary application (approved)
Animal reproductive management: Widely used for reproductive suppression or estrus cycle regulation in animals such as dogs, cats, and horses, such as suppressing estrus in female dogs and controlling sexual behavior in male horses.
Treatment of animal diseases: Used to treat diseases related to sex hormones, such as prostate disease and hyperadrenocorticism in dogs.
Human medical applications (some are in the research/development stage)
Reproductive endocrine disorders: It has been studied for the treatment of hormone-dependent diseases such as precocious puberty, endometriosis, and uterine fibroids.
Prostate cancer and breast cancer: As a GnRH agonist, it can theoretically be used as adjuvant therapy for hormone-sensitive tumors, but other analogues (such as leuprorelin and goserelin) are more commonly used.
Assisted reproductive technology: Pituitary downregulation in controlled ovarian stimulation (COS) cycles has been explored, but the current mainstream clinical drugs are other GnRH analogs.
Outlook & Development
Veterinary application (approved)
Animal reproductive management: Widely used for reproductive suppression or estrus cycle regulation in animals such as dogs, cats, and horses, such as suppressing estrus in female dogs and controlling sexual behavior in male horses.
Treatment of animal diseases: Used to treat diseases related to sex hormones, such as prostate disease and hyperadrenocorticism in dogs.
Human medical applications (some are in the research/development stage)
Reproductive endocrine disorders: It has been studied for the treatment of hormone-dependent diseases such as precocious puberty, endometriosis, and uterine fibroids.
Prostate cancer and breast cancer: As a GnRH agonist, it can theoretically be used as adjuvant therapy for hormone-sensitive tumors, but other analogues (such as leuprorelin and goserelin) are more commonly used.
Assisted reproductive technology: Pituitary downregulation in controlled ovarian stimulation (COS) cycles has been explored, but the current mainstream clinical drugs are other GnRH analogs.
Conclusion
Deslorelin, as a GnRH agonist, is currently primarily valued in the veterinary field, particularly as a mature tool for companion animal reproductive control. In human medicine, its development has stalled due to market competition and patent issues. Future breakthroughs may depend on novel delivery systems or targeted therapy innovations, but it is unlikely to change the existing treatment landscape in the short term.
Frequently Asked Questions
What is Deslorelin?
Deslorelin is a synthetic gonadotropin-releasing hormone (GnRH) analog. It is highly potent, acting approximately 30 to 150 times stronger than natural GnRH.
How does Deslorelin work in the body?
As a GnRH agonist, it initially causes a brief "flare-up" effect, stimulating the release of gonadotropins. With sustained use, it desensitizes the pituitary gland and downregulates GnRH receptors, which ultimately suppresses the production of sex steroid hormones.
What are the approved veterinary applications for Deslorelin?
In veterinary medicine, it is widely used for animal reproductive management, such as suppressing estrus in female dogs and controlling sexual behavior in male horses. It is also used to treat sex hormone-related diseases like canine prostate disease and hyperadrenocorticism.
Can Deslorelin be used in human medicine?
Yes, although primarily in research and development stages. It has been studied for reproductive endocrine disorders (like endometriosis and precocious puberty), as an adjuvant therapy for prostate and breast cancer, and for pituitary downregulation in assisted reproductive technology.
Why is Deslorelin not widely used in human clinics?
Its development in human medicine has stalled largely due to market competition from other more commonly used analogues (such as leuprorelin and goserelin) and patent-related issues.
What is the future outlook for Deslorelin?
While it remains a mature and valued tool in the veterinary field, future breakthroughs in human medicine may rely on novel delivery systems or targeted therapy innovations. However, it is unlikely to drastically change the existing treatment landscape in the short term.
Thin
